Meher Angez

Dr. Meher Angez

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2023 in Journal of the Pakistan Medical Association
Verified
Journal Article
Open access
PDF file
PCPrem Chand
Prem Chand
ASAsna Sulaiman
Asna Sulaiman
MAMeher Angez
Meher Angez
SKSalman Kirmani
Salman Kirmani
Asparagine-linked glycosylation thirteen (ALG13) gene-related congenital disorders of glycosylation (CDGs) include early onset epileptic encephalopathy (EIEE), developmental delays (DD) with intellectual disability (ID), speech and visual abnormalities, and haematologic and endocrine dysfunctions. Worldwide there is a scarcity of available data on this. To add to this scarce data, we report the case of a young girl with this rare genetic mutation who showed remarkable improvement in her seizures by addition of ketogenic diet (KD) to her management regimen. With an already high rate of consanguineous marriages, metabolic and genetic errors are widely prevalent; hence, to bridge the huge gap in the understanding of such diseases, further research and trials are needed to be carried out to improve identification of the disease along with outcomes. Keywords: AGLT13 mutation, epileptic encephalopathy and ketogenic diet.

27 October 2022 in Brain Tumor Research and Treatment
Verified
Journal Article
Open access
PDF file
WRWardah Rafaqat
Wardah Rafaqat
MBMohammad Hamza Bajwa
Mohammad Hamza Bajwa
MAMeher Angez
Meher Angez
SESyed Ather Enam
Syed Ather Enam
Rafaqat W, et al. Brain Tumor Res Treat. 2022 Oct;10(4):226-236. https://doi.org/10.14791/btrt.2022.0014

26 February 2023 in Brain and Spine
Verified
Journal Article
Open access
UWUsama Waqar
Usama Waqar
IAIqra Fatima Munawar Ali
Iqra Fatima Munawar Ali
IFIman Farooqui
Iman Farooqui
SASharjeel Ahmad
Sharjeel Ahmad
ACAhmad Areeb Chaudhry
Ahmad Areeb Chaudhry
MSMuhammad Shahzad Shamim
Muhammad Shahzad Shamim
The effect of chronic steroid therapy on postoperative outcomes after craniotomy for tumor resection remains understudied. This study aimed to fill this gap and to identify risk factors of postoperative morbidity and mortality among patients on chronic steroid use undergoing craniotomy for tumor resection. Data from the American College of Surgeons National Surgical Quality Improvement Program were used. Patients who underwent craniotomy for tumor resection between 2011 and 2019 were included. Perioperative characteristics and complications were compared among patients with and without chronic steroid therapy, defined as steroid use for at least 10 days. Multivariable regression analyses were conducted to assess the impact of steroid therapy on postoperative outcomes. Subgroup analyses involving patients on steroid therapy were conducted to explore risk factors of postoperative morbidity and mortality. Of 27,037 patients, 16.2% were on steroid therapy. On regression analyses, steroid use was significantly associated with any postoperative complication, infectious complication, urinary tract infection, septic shock, wound dehiscence, pneumonia, non-infectious, pulmonary, and thromboembolic complications, cardiac arrest, blood transfusion, unplanned reoperation, readmission, and mortality. On subgroup analysis, risk factors for postoperative morbidity and mortality among patients on steroid therapy included older age, higher American Society of Anesthesiology physical status, functional dependence, pulmonary and cardiovascular comorbidities, anemia, dirty/infected wounds, prolonged operative time, disseminated cancer, and a diagnosis of meningioma. Preoperative brain tumor patients on steroids for 10 or more days are at a relatively high risk of postoperative complications. We recommend a judicious use of steroids in brain tumor patients, both in terms of dosage and duration of treatment.

24 December 2024 in Journal of Ageing and Longevity
Verified
Journal Article
Open access
PDF file
MAMaaha Ayub
Maaha Ayub
MAMeher Angez
Meher Angez
NMNabiha B. Musavi
Nabiha B. Musavi
SRSyed Tabish Rehman
Syed Tabish Rehman
DKDeepak Kumar Kataria
Deepak Kumar Kataria
NJNamirah Jamshed
Namirah Jamshed
Hyponatremia, a common electrolyte imbalance in older adults, results from physiological aging, medication use, and comorbidities, with significant implications for morbidity and quality of life. This narrative review aims to explore the impact of dietary habits and nutritional deficiencies on the development and management of hyponatremia in this population. A literature search identified relevant studies addressing the risk factors related to sodium balance, dietary intake, and nutrition. The key findings reveal that low sodium and age-related changes increase vulnerability to hyponatremia and its associated risks, including cognitive decline and falls. Nutritional strategies, such as optimizing sodium and protein intake and reducing processed food consumption, may offer preventative benefits. Future research should focus on tailored dietary interventions and establishing sodium intake guidelines specific to older adults. Implementing such strategies could improve the health outcomes and reduce the healthcare costs associated with hyponatremia in older populations.

8 July 2026 in Science Translational Medicine
Verified
Journal Article
Closed access
ANArifa Nayab
Arifa Nayab
MMMuhammad Nouman Mughal
Muhammad Nouman Mughal
MAMeher Angez
Meher Angez
SXSansi Xing
Sansi Xing
ABAarohan M. Burma
Aarohan M. Burma
GGGao Guo
Gao Guo
Glioblastoma (GBM) is a devastating cancer with a dismal prognosis. Current treatment includes temozolomide (TMZ), which is more effective in about 50% of GBMs that have O 6 - methylguanine DNA methyltransferase ( MGMT ) promoter methylation. MGMT is a DNA repair protein that reverses TMZ-induced DNA damage. EGFR is a prime oncogene in GBM. Here, we report that EGFR inhibition induced the down-regulation of MGMT in GBM cells, revealing a previously unidentified link between EGFR signaling and response to TMZ. EGFR inhibition led to activation of two transcription factors, activator protein-1 (AP-1), which repressed MGMT transcription, and nuclear factor κB (NF-κB), which up-regulated MGMT transcription. EGFR inhibition also induced AP-1–mediated transcription of miR-616. miR-616 inhibited both MGMT translation and NF-κB activation. Thus, the overall effect of EGFR inhibition was down-regulation of MGMT expression. In addition, we provided an explanation for the prior failure of clinical trials that used concomitant EGFR tyrosine kinase inhibitors (TKIs) and TMZ. TMZ up-regulated MGMT, and concomitant treatment with EGFR TKIs and TMZ failed to down-regulate MGMT. However, pretreatment with EGFR TKIs followed by TMZ efficiently down-regulated MGMT and enhanced TMZ sensitivity in experimental models. Posttreatment tumor tissues from two clinical trials were used to validate these findings. We demonstrated that EGFR inhibitors induced down-regulation of MGMT in posttreatment resected tumor tissues from patients with GBM and the failure of EGFR inhibition to down-regulate MGMT if TMZ was used concomitantly. These data support using EGFR TKIs before TMZ treatment as a therapeutic approach in MGMT unmethylated GBM.

27 February 2026 in HPB
Verified
Journal Article
Open access
QAQaidar Alizai
Qaidar Alizai
OCOdysseas P. Chatzipanagiotou
Odysseas P. Chatzipanagiotou
AMAreesh Mevawalla
Areesh Mevawalla
MAMeher Angez
Meher Angez
AEAbdulaziz Elemosho
Abdulaziz Elemosho
Tim PawlikTim Pawlik
Tim Pawlik
Unplanned postoperative reintubation (UPR) may be associated with subsequent complications and increased mortality. We sought to characterize risk factors and outcomes associated with UPR after liver or pancreatic resections. Adult patients who underwent elective liver or pancreatic surgery were identified in the National Surgical Quality Improvement Project Database (2014-2021). Univariate and multivariable regression analyses were conducted. Among 85,077 patients (liver = 34,892, pancreas = 50,185), 2.3 % (n = 1929) individuals required UPR with a median time to reintubation of 5 days (IQR 2-10). On multivariable regression, risk factors associated with UPR after liver resection included age ≥80 years (aOR = 4.24, 95%CI [2.81-6.38]) and total right lobectomy (aOR = 1.69, 95%CI [1.35-2.13]) while in the pancreatic surgery cohort, the risk factors included Whipple procedure (aOR = 1.64, 95%CI [1.40-1.92]) and pancreatic fistula (aOR = 2.50, 95%CI [2.11-2.97]). UPR was strongly associated with longer LOS (Liver∼+8.00 days; Pancreas∼+6.33 days) and 30-day mortality (aOR, Liver = 38.26; Pancreas = 17.38). UPR occurred in ∼2 % of patients after liver and pancreatic resection. Risk factors and outcomes differed by organ, but UPR consistently marked severe postoperative deterioration substantially high mortality.